I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
This is an open-label, single-arm study to evaluate the safety and efficacy of Ibrutinib in subjects with refractory/relapsed autoimmune hemolytic anemia.
ibrutinib
anemia
rituximab
- 0 views
- 05 Aug, 2020
Ibrutinib + Venetoclax in Untreated WM
The names of the study drugs involved in this study are: Venetoclax ibrutinib
bone marrow biopsy
ibrutinib
absolute neutrophil count
growth factor
venetoclax
- 0 views
- 16 Feb, 2024
- 2 locations